Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank83
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
3.32
↓ 100% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthCompressed
Average
4018.76
Historical baseline
PeriodValueYoY Change
20243.32-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-100.0%
201828127.97-